MedTech startup developing an automated IVD medical device for detecting and identifying all human pathogens & AMR genes on one test panel.
PathoGene has raised $500K in total funding. The most recent round was Seed. The last funding was announced in July 2021.
PathoGene's investors include Joseph Mickel.
PathoGene is headquartered in Los Angeles, United States.
MedTech startup developing an automated IVD medical device for detecting and identifying all human pathogens & AMR genes on one test panel.
PathoGene is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PathoGene — Funding & Investors." VCBacked, July 14, 2021, https://www.vcbacked.co/company/pathogene. Accessed August 14, 2026.
VCBacked. (2021). PathoGene — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pathogene
{{cite web |title=PathoGene — Funding & Investors |url=https://www.vcbacked.co/company/pathogene |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated